Scynexis (SCYX) Cost of Revenue (2013 - 2023)
Scynexis (SCYX) posted Cost of Revenue of $14.7 million for Q4 2023, up 3774.41% on a QoQ basis from $379000.0 in Q3 2023, and up 7391.84% year-over-year from $196000.0 in Q4 2022.
Scynexis (SCYX) Cost of Revenue (2013 - 2023) Analysis & Trends
Scynexis' Cost of Revenue history runs 6 years deep, the most recent figure standing at $14.7 million for Q4 2023.
- Quarterly Cost of Revenue rose 7391.84% year-over-year to $14.7 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $14.7 million (up 1190.33% YoY) and the FY2023 annual result came in at $15.6 million, up 2387.9% from the prior year.
- Cost of Revenue was $14.7 million for Q4 2023 at Scynexis, up from $379000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $14.7 million in Q4 2023 and bottomed at $99000.0 in Q1 2022.
- A 3-year average of $1.7 million and a median of $178000.0 in 2021 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2022 — Cost of Revenue increased 17.37% — and 2023, when it surged 7391.84%.
- Scynexis' Cost of Revenue stood at $167000.0 in 2021, then increased by 17.37% to $196000.0 in 2022, then jumped by 7391.84% to $14.7 million in 2023.
- Business Quant data shows SCYX's Cost of Revenue at $14.7 million in Q4 2023, $379000.0 in Q3 2023, and $426000.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 2.01 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 641.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 2.59 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 133.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 2.36 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 13.80 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 586.00 Mn |
| 10 | Scynexis | 23.19 Mn | -13.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 14.68 Mn |
| Dec 31, 2023 | 14.68 Mn |
| Sep 30, 2023 | 379,000.00 |
| Sep 30, 2023 | 379,000.00 |
| Jun 30, 2023 | 426,000.00 |
| Jun 30, 2023 | 426,000.00 |
| Mar 31, 2023 | 137,000.00 |
| Mar 31, 2023 | 137,000.00 |
| Dec 31, 2022 | 196,000.00 |
| Dec 31, 2022 | 196,000.00 |
| Sep 30, 2022 | 189,000.00 |
| Sep 30, 2022 | 189,000.00 |
| Jun 30, 2022 | 144,000.00 |
| Jun 30, 2022 | 144,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Mar 31, 2022 | 99,000.00 |
| Dec 31, 2021 | 167,000.00 |
| Dec 31, 2021 | 167,000.00 |
| Sep 30, 2021 | 145,000.00 |
| Sep 30, 2021 | 145,000.00 |